Search Results - "ACKER, H"

Refine Results
  1. 1

    CD56 in the Immune System: More Than a Marker for Cytotoxicity? by Van Acker, Heleen H, Capsomidis, Anna, Smits, Evelien L, Van Tendeloo, Viggo F

    Published in Frontiers in immunology (24-07-2017)
    “…Over the past years, the phenotypic and functional boundaries distinguishing the main cell subsets of the immune system have become increasingly blurred. In…”
    Get full text
    Journal Article
  2. 2

    Bisphosphonates for cancer treatment: Mechanisms of action and lessons from clinical trials by Van Acker, Heleen H, Anguille, Sébastien, Willemen, Yannick, Smits, Evelien L, Van Tendeloo, Viggo F

    Published in Pharmacology & therapeutics (Oxford) (01-02-2016)
    “…A growing body of evidence points toward an important anti-cancer effect of bisphosphonates, a group of inexpensive, safe, potent, and long-term stable…”
    Get full text
    Journal Article
  3. 3

    Chimeric Antigen Receptor-Modified T Cell Therapy in Multiple Myeloma: Beyond B Cell Maturation Antigen by Timmers, Marijke, Roex, Gils, Wang, Yuedi, Campillo-Davo, Diana, Van Tendeloo, Viggo F I, Chu, Yiwei, Berneman, Zwi N, Luo, Feifei, Van Acker, Heleen H, Anguille, Sébastien

    Published in Frontiers in immunology (16-07-2019)
    “…Chimeric antigen receptor (CAR)-modified T cell therapy is a rapidly emerging immunotherapeutic approach that is revolutionizing cancer treatment. The…”
    Get full text
    Journal Article
  4. 4

    Interleukin-15 enhances the proliferation, stimulatory phenotype, and antitumor effector functions of human gamma delta T cells by Van Acker, Heleen H, Anguille, Sébastien, Willemen, Yannick, Van den Bergh, Johan M, Berneman, Zwi N, Lion, Eva, Smits, Evelien L, Van Tendeloo, Viggo F

    Published in Journal of hematology and oncology (29-09-2016)
    “…Adoptive immunotherapy is gaining momentum to fight malignancies, whereby γδ T cells have received recent attention as an alternative cell source as to natural…”
    Get full text
    Journal Article
  5. 5

    Interleukin-15 Dendritic Cells Harness NK Cell Cytotoxic Effector Function in a Contact- and IL-15-Dependent Manner by Anguille, Sébastien, Van Acker, Heleen H, Van den Bergh, Johan, Willemen, Yannick, Goossens, Herman, Van Tendeloo, Viggo F, Smits, Evelien L, Berneman, Zwi N, Lion, Eva

    Published in PloS one (07-05-2015)
    “…The contribution of natural killer (NK) cells to the treatment efficacy of dendritic cell (DC)-based cancer vaccines is being increasingly recognized. Much…”
    Get full text
    Journal Article
  6. 6

    Interleukin-15-Cultured Dendritic Cells Enhance Anti-Tumor Gamma Delta T Cell Functions through IL-15 Secretion by Van Acker, Heleen H, Anguille, Sébastien, De Reu, Hans, Berneman, Zwi N, Smits, Evelien L, Van Tendeloo, Viggo F

    Published in Frontiers in immunology (10-04-2018)
    “…Dendritic cell (DC) vaccination can be an effective post-remission therapy for acute myeloid leukemia (AML). Yet, current DC vaccines do not encompass the…”
    Get full text
    Journal Article
  7. 7

    The good, the bad and the ugly in oxygen-sensing: ROS, cytochromes and prolyl-hydroxylases by Acker, Till, Fandrey, Joachim, Acker, Helmut

    Published in Cardiovascular research (15-07-2006)
    “…Current concepts of cellular oxygen-sensing include an isoform of the neutrophil NADPH oxidase, different electron carrier units of the mitochondrial electron…”
    Get full text
    Journal Article
  8. 8

    Laser-induced vapor nanobubbles improve diffusion in biofilms of antimicrobial agents for wound care by Teirlinck, E., Fraire, J.C., Van Acker, H., Wille, J., Swimberghe, R., Brans, T., Xiong, R., Meire, M., De Moor, R.J.G., De Smedt, S.C., Coenye, T., Braeckmans, K.

    Published in Biofilm (01-12-2019)
    “…Being responsible for delayed wound healing, the presence of biofilms in infected wounds leads to chronic, and difficult to treat infections. One of the…”
    Get full text
    Journal Article
  9. 9

    Type I cell ROS kinetics under hypoxia in the intact mouse carotid body ex vivo: a FRET-based study by Bernardini, A, Brockmeier, U, Metzen, E, Berchner-Pfannschmidt, U, Harde, E, Acker-Palmer, A, Papkovsky, D, Acker, H, Fandrey, J

    “…Reactive oxygen species (ROS) mainly originating from NADPH oxidases have been shown to be involved in the carotid body (CB) oxygen-sensing cascade. For…”
    Get more information
    Journal Article
  10. 10

    Two‐photon fluorescence absorption and emission spectra of dyes relevant for cell imaging by Bestvater, F., Spiess, E., Stobrawa, G., Hacker, M., Feurer, T., Porwol, T., Berchner‐Pfannschmidt, U., Wotzlaw, C., Acker, H.

    Published in Journal of microscopy (Oxford) (01-11-2002)
    “…Summary Two‐photon absorption and emission spectra for fluorophores relevant in cell imaging were measured using a 45 fs Ti:sapphire laser, a continuously…”
    Get full text
    Journal Article
  11. 11

    Human blood myeloid and plasmacytoid dendritic cells cross activate each other and synergize in inducing NK cell cytotoxicity by van Beek, Jasper J. P., Gorris, Mark A. J., Sköld, Annette E., Hatipoglu, Ibrahim, Van Acker, Heleen H., Smits, Evelien L., de Vries, I. Jolanda M., Bakdash, Ghaith

    Published in Oncoimmunology (01-01-2016)
    “…Human blood dendritic cells (DCs) hold great potential for use in anticancer immunotherapies. CD1c + myeloid DCs and plasmacytoid DCs (pDCs) have been…”
    Get full text
    Journal Article
  12. 12

    Chimeric Antigen Receptor-Engineered Human Gamma Delta T Cells: Enhanced Cytotoxicity with Retention of Cross Presentation by Capsomidis, Anna, Benthall, Gabriel, Van Acker, Heleen H., Fisher, Jonathan, Kramer, Anne M., Abeln, Zarah, Majani, Yvonne, Gileadi, Talia, Wallace, Rebecca, Gustafsson, Kenth, Flutter, Barry, Anderson, John

    Published in Molecular therapy (07-02-2018)
    “…Gamma delta T (γδT) lymphocytes are primed for rapid function, including cytotoxicity toward cancer cells, and are a component of the immediate stress…”
    Get full text
    Journal Article
  13. 13

    How metabolism bridles cytotoxic CD8+ T cells through epigenetic modifications by Van Acker, Heleen H., Ma, Shixin, Scolaro, Tommaso, Kaech, Susan M., Mazzone, Massimiliano

    Published in Trends in immunology (01-05-2021)
    “…In the direct competition for metabolic resources between cancer cells and tumor-infiltrating CD8+ T cells, the latter are bound to lose out. These effector…”
    Get full text
    Journal Article
  14. 14

    BDCA1+CD14+ Immunosuppressive Cells in Cancer, a Potential Target? by van Ee, Thomas J, Van Acker, Heleen H, van Oorschot, Tom G, Van Tendeloo, Viggo F, Smits, Evelien L, Bakdash, Ghaith, Schreibelt, Gerty, de Vries, I Jolanda M

    Published in Vaccines (Basel) (19-09-2018)
    “…Dendritic cell (DC) vaccines show promising effects in cancer immunotherapy. However, their efficacy is affected by a number of factors, including (1) the…”
    Get full text
    Journal Article
  15. 15

    Two‐photon excitation and emission spectra of the green fluorescent protein variants ECFP, EGFP and EYFP by SPIESS, E., BESTVATER, F., HECKEL‐POMPEY, A., TOTH, K., HACKER, M., STOBRAWA, G., FEURER, T., WOTZLAW, C., BERCHNER‐PFANNSCHMIDT, U., PORWOL, T., ACKER, H.

    Published in Journal of microscopy (Oxford) (01-03-2005)
    “…Summary Two‐photon (TP) excitation (820–1150 nm) and emission (280–700 nm) spectra for the fluorescent proteins (FPs) ECFP3, EGFP3 and EYFP3 produced in human…”
    Get full text
    Journal Article
  16. 16

    Dilated cardiomyopathy caused by a novel TNNT2 mutation—Added value of genetic testing in the correct identification of affected subjects by Van Acker, H, De Sutter, J, Vandekerckhove, K, de Ravel, Th. JL, Verhaaren, H, De Backer, J

    Published in International journal of cardiology (08-10-2010)
    “…Abstract Diagnosing familial dilated cardiomyopathy requires careful family history taking and clinical evaluation in first degree relatives. Based on the…”
    Get full text
    Journal Article
  17. 17

    Dendritic Cells as Pharmacological Tools for Cancer Immunotherapy by Anguille, Sébastien, Smits, Evelien L, Bryant, Christian, Van Acker, Heleen H, Goossens, Herman, Lion, Eva, Fromm, Phillip D, Hart, Derek N, Van Tendeloo, Viggo F, Berneman, Zwi N

    Published in Pharmacological reviews (01-10-2015)
    “…Although the earliest—rudimentary—attempts at exploiting the immune system for cancer therapy can be traced back to the late 18th Century, it was not until the…”
    Get full text
    Journal Article
  18. 18

    The quiet (energy) revolution: Analysing the dissemination of photovoltaic power systems in Kenya by Acker, Richard H, Kammen, Daniel M

    Published in Energy policy (1996)
    “…The widespread introduction and adoption of renewable energy technologies remains high on virtually every national development policy agenda; renewable energy…”
    Get full text
    Journal Article
  19. 19

    The role of the common gamma-chain family cytokines in γδ T cell-based anti-cancer immunotherapy by Van Acker, Heleen H., Campillo-Davo, Diana, Roex, Gils, Versteven, Maarten, Smits, Evelien L., Van Tendeloo, Viggo F.

    Published in Cytokine & growth factor reviews (01-06-2018)
    “…•The cytokines of the common gamma-chain receptor family all have their unique effects on γδ T cells.•Interleukin-15-activated γδ T cells arise as strong…”
    Get full text
    Journal Article
  20. 20

    Immunohistochemical demonstration of four subunits of neutrophil NAD(P)H oxidase in type I cells of carotid body by Kummer, W, Acker, H

    Published in Journal of applied physiology (1985) (01-05-1995)
    “…We demonstrate, by means of immunohistochemistry, that type I cells of human, guinea pig, and rat carotid bodies react with antisera raised against the…”
    Get more information
    Journal Article